Author:
Yan Tongmeng,Gao Song,Peng Xiaojuan,Shi Jian,Xie Cong,Li Qiang,Lu Linlin,Wang Ying,Zhou Fuyuan,Liu Zhongqiu,Hu Ming
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Organic Chemistry,Pharmaceutical Science,Pharmacology,Molecular Medicine,Biotechnology
Reference41 articles.
1. Sharma RR. Enzyme Inhibition and Bioapplications. In: Badal S, Shields M, Delgoda R, editors. Cytochrome P450 Enzyme Inhibitors, Nature InTech, 2012, p. 39–56
2. Ruano G, Villagra D, Szarek B, Windemuth A, Kocherla M, Gorowski K, et al. Physiogenomic analysis of CYP450 drug metabolism correlates dyslipidemia with pharmacogenetic functional status in psychiatric patients. Biomark Med. 2011;5:439–49.
3. Liu J, Tawa GJ, Wallqvist A. Identifying cytochrome P450 functional networks and their allosteric regulatory elements. PLoS One. 2013;8:e81980.
4. Rowland A, Miners JO, Mackenzie PI. The UDP-glucuronosyltransferases: their role in drug metabolism and detoxification. Int J Biochem Cell Biol. 2013;45:1121–32.
5. Issue S. The 64th annual meeting of the american association for the study of liver diseases: the liver meeting 2013. HBV Epidemiol Prev Hepatol. 2013;58:607A–26A.
Cited by
42 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献